Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | MTSR Metsera | Common Stock | Buy | Acquire P | Yes | No | 18 | 789,998 | 14.22 mm | 8,313,680 |
3 Feb 25 | MTSR Metsera | Common Stock | Buy | Acquire P | Yes | No | 18 | 1,432,224 | 25.78 mm | 18,503,128 |
3 Feb 25 | MTSR Metsera | Common Stock | Conversion | Acquire C | Yes | No | 0 | 7,523,682 | 0.00 | 7,523,682 |
3 Feb 25 | MTSR Metsera | Common Stock | Conversion | Acquire C | Yes | No | 0 | 16,006,949 | 0.00 | 17,070,904 |
3 Feb 25 | MTSR Metsera | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 2,678,571 | 0.00 | 0 |
3 Feb 25 | MTSR Metsera | Series A Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 15,000,000 | 0.00 | 0 |
3 Feb 25 | MTSR Metsera | Series B Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 2,678,571 | 0.00 | 0 |
3 Feb 25 | MTSR Metsera | Series A Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 15,000,000 | 0.00 | 0 |
3 Feb 25 | MTSR Metsera | Series Seed Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 19,933,333 | 0.00 | 0 |
14 Jun 24 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 2.36 | 130,000 | 306.80 k | 130,000 |